ArticleOncotarget2017

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.

Anne-Sophie Chretien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.